[Cost-effectiveness of universal childhood vaccination against hepatitis A in Spain: a dynamic approach]Article Published on 2023-03-012023-05-31 Journal: Gaceta sanitaria [Category] A형 간염, [키워드] Análisis de coste-beneficio Child Cost-benefit analysis España Hepatitis A vaccines Infant Lactantes mass vaccination Preescolares Spain Vacunación masiva Vacunas frente a la hepatitis A. [DOI] 10.1016/j.gaceta.2023.102292 PMC 바로가기
Strategies to tackle SARS-CoV-2 Mu, a newly classified variant of interest likely to resist currently available COVID-19 vaccines현재 사용 가능한 COVID-19 백신에 저항할 가능성이 있는 새로 분류된 관심 변종인 SARS-CoV-2 Mu에 대처하기 위한 전략Article Published on 2022-12-312022-09-11 Journal: Human vaccines & immunotherapeutics [Category] COVID19(2023년), MERS, SARS, 변종, 유전자 메커니즘, 진단, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 administration adopted approach B.1 lineage B.1.621 BNT161b2 booster dose Characteristics coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 vaccine COVID-19 vaccine development Evidence exacerbated Genetic genomic Genomic surveillance global mass vaccination Health implementation infections Intervention Lineage mass vaccination Mu variant mutations Neutralizing non-pharmaceutical interventions (NPIs) NPIs potential risk public health measure public health measures Recombination reported required respiratory restrict SARS-CoV-2 SARS-CoV-2 B.1.621 SARS-CoV-2 virus sera shown Strains Strategy sub-lineage B.1.621.1 Surveillance survivor the SARS-CoV-2 virus therapeutic threat vaccination Vaccine vaccine breakthrough. Vaccine development variant variants [DOI] 10.1080/21645515.2022.2027197 PMC 바로가기 [Article Type] Article
COVID-19 mass vaccination – an illustration of the impact of syringe choice on the effectiveness of mass vaccination campaignsArticle Published on 2022-12-012023-07-08 Journal: Emerging Microbes & Infections [Category] COVID19(2023년), [키워드] COVID-19 mass vaccination medical device public health vaccination capacity. [DOI] 10.1080/22221751.2022.2048968 PMC 바로가기
Comparative effectiveness and durability of COVID-19 vaccination against death and severe disease in an ongoing nationwide mass vaccination campaign진행중인 전국적인 대규모 예방접종 캠페인에서 COVID-19 사망 및 중증 질환에 대한 예방접종의 비교 효과 및 지속성Article Published on 2022-10-012022-09-11 Journal: Journal of medical virology [Category] COVID19(2023년), SARS, 변종, [키워드] 95% confidence interval Active surveillance acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 Ad26 Ad26.COV2.S adjusted age all age groups approved BNT162b2 ChAdOx1 ChAdOx1 nCoV-19 Cohort Cohort studies Comparative coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 vaccination COVID-19 vaccines death dose doses Effectiveness effort immunogenicity intubation mass vaccination morbidity Mortality mRNA mRNA-1273 National of BNT162b2 offer offered pandemic prevented reduce registry data remained SARS-CoV-2 severe disease study period vaccinate vaccination Vaccine vaccine effectiveness. variant variants waned were used [DOI] 10.1002/jmv.27934 PMC 바로가기 [Article Type] Article
Can high COVID-19 vaccination rates in adults help protect unvaccinated children? Evidence from a unique mass vaccination campaign, Schwaz/Austria, March 2021Article Published on 2022-09-012022-11-16 Journal: Eurosurveillance [Category] SARS, 변종, [키워드] approaches Beta BNT162b2 mRNA Can children Cohort complementary COVID-19 COVID-19 vaccination Europe Evidence help indirect protective effect individual Infection infection rate mass vaccination offer offered outbreak population immunity population immunity. PROTECT Protective provided reduction Region regions remained Spread the SARS-CoV-2 unique vaccinated individual vaccination Vaccine variant [DOI] 10.2807/1560-7917.ES.2022.27.39.2101027 PMC 바로가기
Detecting SARS-CoV-2 neutralizing immunity: highlighting the potential of split nanoluciferase technologySARS-CoV-2 중화 면역 검출: 분할 나노루시페라제 기술의 잠재력 강조Review Published on 2022-08-172022-09-11 Journal: Journal of Molecular Cell Biology [Category] SARS, 변종, 진단, 치료기술, [키워드] acquired immunity acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 biosafety coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 detect focus gold gold standard Health highlighting hour humoral immune Immune escape immune escape mutants Immunity immunity passport individual individual variations Infection mass vaccination nanoluciferase neutralization test Neutralizing Neutralizing antibodies neutralizing antibody pandemic plaque reduction neutralization progressed pros PROTECT protective antibodies Protective antibody protective immunity respiratory SARS-CoV-2 SARS-CoV-2 neutralizing antibodies severe acute respiratory syndrome Coronavirus split nanoluciferase subsequent surrogate virus neutralization test titers vaccination Variation Virus neutralization virus-like particles virus-like particles. [DOI] 10.1093/jmcb/mjac023 PMC 바로가기 [Article Type] Review
Effectiveness of third vaccine dose for coronavirus disease 2019 during the Omicron variant pandemic: a prospective observational study in Japan오미크론 변종 대유행 중 코로나바이러스 질병 2019에 대한 3차 백신 접종의 효과: 일본의 전향적 관찰 연구Observational Study Published on 2022-08-102022-09-11 Journal: Scientific Reports [Category] SARS, 변종, 임상, [키워드] 95% confidence interval administration booster dose caused Chain Reaction close contact contact with coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 cases COVID-19 vaccine dose doses Effectiveness enrolled evaluated highest Infection Japan mass vaccination mRNA Nasopharyngeal swab nasopharyngeal swab sample Nasopharyngeal swab samples occurred omicron Omicron variant outbreak participant Participants polymerase chain reaction Prevent progressed progression prospective observational study receiving Ribonucleic acid RT-PCR RT-PCR test Swab test tested vaccination Vaccine vaccine dose variant were excluded with COVID-19 [DOI] 10.1038/s41598-022-17990-7 PMC 바로가기 [Article Type] Observational Study
Atorvastatin for reduction of 28-day mortality in hospitalized COVID-19 patients: study protocol for a randomized, double-blinded, placebo-controlled, clinical trial입원한 COVID-19 환자의 28일 사망률 감소를 위한 아토르바스타틴: 무작위, 이중 맹검, 위약 대조, 임상 시험을 위한 연구 프로토콜Article Published on 2022-08-082022-09-11 Journal: Trials [Category] SARS, 임상, [키워드] 28-day mortality 95% confidence interval Acute kidney injury added adjusted odds ratio All participants all-cause mortality anti-inflammatory drug approval assigned atorvastatin being clinical Clinical improvement clinical trial clinician Consequences Consistency coronavirus COVID-19 COVID-19 patient Delta disease double-blinded drug events healthcare worker Hmg coa hospital hospitalized COVID-19 hospitalized patients In-hospital in-hospital mortality Informed consent institutional review board intensive care isolation hospital logistic regression model mass vaccination mechanical ventilation Mortality neurological once daily P-value pandemic pandemic era participant Patient performed Placebo placebo-controlled Primary outcome protocol Psychological Randomized randomized clinical trial Randomized controlled trial receive recruited reduce mortality reduced reduction Registered registry Research SARS-CoV-2 Sepsis severity severity of COVID-19 standard treatment statins statins. Study protocol supported Tablet the patient university vaccination [DOI] 10.1186/s13063-022-06619-9 PMC 바로가기 [Article Type] Article
BSL2-compliant lethal mouse model of SARS-CoV-2 and variants of concern to evaluate therapeutics targeting the Spike proteinSARS-CoV-2의 BSL2 호환 치명적인 마우스 모델 및 Spike 단백질을 표적으로 하는 치료제 평가를 위한 우려 변종Article Published on 2022-07-282022-09-11 Journal: Frontiers in Immunology [Category] COVID19(2023년), SARS, 변종, [키워드] ACE2 ACE2 transgenic mice acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 animal model antibody both virus both viruses brains BSL-2 BSL-2 mouse model BSL2 BSL3 BST2 can be used CCL5 change competent concern conditions coronavirus COVID-19 COVID19 CXCL10 disease Disease progression drugs Encephalitis evaluate experimental therapeutics facilitate faster generate GFP glycoprotein hACE2 host-pathogen interactions in vivo increased expression Infection interferon IRF7 K18-hACE2 K18-hACE2 transgenic mice lethal infection LILRB4 lung Lungs mass vaccination mice modulate mouse model mutations Neonatal neuronal infection neurotropism pathogenicity prophylactic treatment Protein pseudotyped Pseudotyped virus Receptor binding domain replaced REPLACED BY Replication reported SARS-CoV-2 SARS-CoV-2 spike protein SARS-CoV-2 variants SARS-CoV-2 viruses SARS2 severe acute respiratory syndrome Coronavirus Spike protein spike protein. stomatitis successive wave successive waves the SARS-CoV-2 the Spike the spike protein therapeutic Therapeutics transgenic transgenic mice Transmission vaccination Vaccine development variant variants of concern vesicular vesicular stomatitis vesicular stomatitis virus virulence virus virus VoC VSV VSV (vesicular stomatitis virus) [DOI] 10.3389/fimmu.2022.919815 PMC 바로가기 [Article Type] Article
Six-Month Follow-Up of Immune Responses after a Rapid Mass Vaccination against SARS-CoV-2 with BNT162b2 in the District of Schwaz/AustriaSchwaz/Austria 지역에서 BNT162b2를 사용한 SARS-CoV-2에 대한 신속한 대량 백신 접종 후 면역 반응의 6개월 추적Article Published on 2022-07-272022-09-11 Journal: Viruses [Category] COVID19(2023년), MERS, SARS, 변종, 진단, 치료기술, [키워드] age Analysis antibody Antibody Response B-cell response B.1.351 Beta BNT162b2 carried correlated COVID-19 detect District enrolment evaluate immune response immune responses Infection mass mass vaccination natural infection new SARS-CoV-2 no correlation outbreak participant participated preserved provide Rapid reduction in response robust SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 infections second dose Seropositivity Serum level serum levels specific antibodies spring study participant subject Support T cell T cell response T cell responses T-cell Response the District the SARS-CoV-2 vaccination vaccination. variant waned was measured [DOI] 10.3390/v14081642 PMC 바로가기 [Article Type] Article